期刊文献+

Prognostic value of innate and adaptive immunity in colorectal cancer 被引量:6

Prognostic value of innate and adaptive immunity in colorectal cancer
下载PDF
导出
摘要 Colorectal cancer(CRC) remains one of the major public health problems throughout the world.Originally depicted as a multi-step dynamical disease,CRC develops slowly over several years and progresses through cytologically distinct benign and malignant states,from single crypt lesions through adenoma,to malignant carcinoma with the potential for invasion and metastasis.Moving from histological observations since a long time,it has been recognized that inflammation and immunity actively participate in the pathogenesis,surveillance and progression of CRC.The advent of immunohistochemical techniques and of animal models has improved our understanding of the immune dynamical system in CRC.It is well known that immune cells have variable behavior controlled by complex interactions in the tumor microenvironment.Advances in immunology and molecular biology have shown that CRC is immunogenic and that host immune responses influence survival.Several lines of evidence support the concept that tumor stromal cells,are not merely a scaffold,but rather they influence growth,survival,and invasiveness of cancer cells,dynamically contributing to the tumor microenvironment,together with immune cells.Different types of immune cells infiltrate CRC,comprising cells of both the innate and adaptive immune system.A relevant issue is to unravel the discrepancy between the inhibitory effects on cancer growth exerted by the local immune response and the promoting effects on cancer proliferation,invasion,and dissemination induced by some types of inflammatory cells.Here,we sought to discuss the role played by innate and adaptive immune system in the local progression and metastasis of CRC,and the prognostic information that we can currently understand and exploit. Colorectal cancer (CRC) remains one of the major public health problems throughout the world. Originally depicted as a multi-step dynamical disease, CRC develops slowly over several years and progresses through cytologically distinct benign and malignant states, from single crypt lesions through adenoma, to malignant carcinoma with the potential for invasion and metastasis. Moving from histological observations since a long time, it has been recognized that inflammation and immunity actively participate in the pathogenesis, surveillance and progression of CRC. The advent of immunohistochemical techniques and of animal models has improved our understanding of the immune dynamical system in CRC. It is well known that immune cells have variable behavior controlled by complex interactions in the tumor microenvironment. Advances in immunology and molecular biology have shown that CRC is immunogenic and that host immune responses influence survival. Several lines of evidence support the concept that tumor stromal cells, are not merely a scaffold, but rather they influence growth, survival, and invasiveness of cancer cells, dynamically contributing to the tumor microenvironment, together with immune cells. Different types of immune cells infiltrate CRC, comprising cells of both the innate and adaptive immune system. A relevant issue is to unravel the discrepancy between the inhibitory effects on cancer growth exerted by the local immune response and the promoting effects on cancer proliferation, invasion, and dissemination induced by some types of inflammatory cells. Here, we sought to discuss the role played by innate and adaptive immune system in the local progression and metastasis of CRC, and the prognostic information that we can currently understand and exploit.
出处 《World Journal of Gastroenterology》 SCIE CAS 2013年第2期174-184,共11页 世界胃肠病学杂志(英文版)
基金 Supported by Ministry of Education,University and Research (MIUR),Target Project Oncologia 2006 Alliance Against Cancer the Italian Association for Cancer Research Grant Project,No. IG5256
关键词 COLORECTAL cancer IMMUNITY INFLAMMATION PROGNOSIS METASTASIS Colorectal cancer Immunity Inflammation Prognosis Metastasis
  • 相关文献

参考文献17

  • 1Vijay G. Peddareddigari,Dingzhi Wang,Raymond N. DuBois.The Tumor Microenvironment in Colorectal Carcinogenesis[J].Cancer Microenvironment.2010(1)
  • 2Jennifer L. Barnas,Michelle R. Simpson-Abelson,Sandra J. Yokota,Raymond J. Kelleher,Richard B. Bankert.T Cells and Stromal Fibroblasts in Human Tumor Microenvironments Represent Potential Therapeutic Targets[J].Cancer Microenvironment.2010(1)
  • 3Hiroyuki Suzuki,Nobuhito Chikazawa,Takehiko Tasaka,Junji Wada,Akio Yamasaki,Yoshiki Kitaura,Masae Sozaki,Masao Tanaka,Hideya Onishi,Takashi Morisaki,Mitsuo Katano.Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer[J].Cancer Immunology Immunotherapy.2010(5)
  • 4László Herszényi,Ferenc Sipos,Orsolya Galamb,Norbert Solymosi,István Hritz,Pál Miheller,Lajos Berczi,Béla Molnár,Zsolt Tulassay.Matrix Metalloproteinase-9 Expression in the Normal Mucosa–Adenoma–Dysplasia–Adenocarcinoma Sequence of the Colon[J].Pathology & Oncology Research.2008(1)
  • 5Alberto Mantovani,Tiziana Schioppa,Chiara Porta,Paola Allavena,Antonio Sica.Role of tumor-associated macrophages in tumor progression and invasion[J].Cancer and Metastasis Reviews.2006(3)
  • 6Annette Paschen,Stefan Eichmuller,Dirk Schadendorf.Identification of tumor antigens and T-cell epitopes, and its clinical application[J].Cancer Immunology Immunotherapy.2004(3)
  • 7Randall F. Holcombe,Joth Jacobson,Shaker R. Dakhil,Ruby M. Stewart,Kenneth S. Betzing,Krishna Kannan,John S. Macdonald.Association of immune parameters with clinical outcome in stage III colon cancer: results of Southwest Oncology Group Protocol 9009[J].Cancer Immunology Immunotherapy.1999(9)
  • 8P Salama,C Platell.Host response to colorectal cancer[].Anz Journal of Surgery.2008
  • 9M Saleh,G Trinchieri.Innate immune mechanisms of colitis and colitis-associated colorectal cancer[].Nature Reviews Immunology.2011
  • 10Ferrone C,Dranoff G.Dual roles for immunity in gastrointestinal cancers[].Journal of Clinical Oncology.2010

同被引文献136

  • 1Shigeo Koido,Toshifumi Ohkusa,Sadamu Homma,Yoshihisa Namiki,Kazuki Takakura,Keisuke Saito,Zensho Ito,Hiroko Kobayashi,Mikio Kajihara,Kan Uchiyama,Seiji Arihiro,Hiroshi Arakawa,Masato Okamoto,Jianlin Gong,Hisao Tajiri.Immunotherapy for colorectal cancer[J].World Journal of Gastroenterology,2013,19(46):8531-8542. 被引量:11
  • 2刘金玲,姚良权,聂陆安.疏肝健脾治疗与肝郁脾虚因素刺激对大肠癌大鼠免疫功能变化的探讨[J].国际医药卫生导报,2006,12(3):4-6. 被引量:8
  • 3Hermann Brenner,Matthias Kloor,Christian Peter Pox.Colorectal cancer[J]. The Lancet . 2013
  • 4Giuseppe Curigliano,Carmen Criscitiello,Lucia Gelao,Aron Goldhirsch.Molecular Pathways: Human Leukocyte Antigen G (HLA-G)[J].Clinical Cancer Research.2013(20)
  • 5Wolf-Herman Fridman,Marie-Caroline Dieu-Nosjean,Franck Pagès,Isabelle Cremer,Diane Damotte,Catherine Sautès-Fridman,Jér?me Galon.The Immune Microenvironment of Human Tumors: General Significance and Clinical Impact[J].Cancer Microenvironment.2013(2)
  • 6Signe Goul Svendsen,Basil M. Hantash,Longmei Zhao,Carsten Faber,Michael Bzorek,Mogens Holst Nissen,Thomas Vauvert F. Hviid.The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3′-untranslated region[J].Human Immunology.2013(7)
  • 7A. Sabbagh,D. Courtin,J. Milet,J. D. Massaro,E. C. Castelli,F. Migot‐Nabias,B. Favier,N. Rouas‐Freiss,P. Moreau,A. Garcia,E. A. Donadi.Association of HLA‐G 3′ untranslated region polymorphisms with antibody response against Plasmodium falciparum antigens: preliminary results[J].Tissue Antigens.2013(1)
  • 8C. Koudougou,M. Bonneville,T. Matysiak‐Budnik,Y. Touchefeu.Review article: antitumoural immunity in colorectal cancer – current and potential future implications in clinical practice[J].Aliment Pharmacol Ther.2013(1)
  • 9Estibaliz Alegre,Vera Rebmann,Joel LeMaoult,Carmen Rodriguez,Peter A. Horn,Angel Díaz‐Lagares,José I. Echeveste,Alvaro González.In vivo identification of an HLA ‐ G complex as ubiquitinated protein circulating in exosomes[J].Eur J Immunol.2013(7)
  • 10Kerry S. Campbell,Jun Hasegawa.NK cell biology: An update and future directions[J].The Journal of Allergy and Clinical Immunology.2013

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部